ArticleTranslational cancer research2020

Pretreatment neutrophil-to-lymphocyte ratio is a predictive biomarker for EGFR TKI-treated patients with advanced EGFR-mutant Non-small cell lung cancer.

Cong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.